Concepedia

Shinobu Kawauchi-Miki

SK

Statistics

Publications

5

Citations

557

H-Index

5

Active since

2010

Affiliations

Shionogi (Japan)(Current)

GlaxoSmithKline (United States)

Futaba (Japan)

Research Triangle Park Foundation

Shinobu Kawauchi-Miki is an author at Shionogi (Japan) specializing in virology, antiviral resistance, and antiviral drug resistance.

Publications per year

2010–2019

5

Publications

5

<i>In Vitro</i>Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2010 · 377 citations · Full text

, , +17

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection

Tomokazu Yoshinaga, Masanori Kobayashi, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

, , +17

Effects of Raltegravir or Elvitegravir Resistance Signature Mutations on the Barrier to Dolutegravir Resistance <i>In Vitro</i>

Takahiro Seki, Akemi Suyama-Kagitani, Shinobu Kawauchi-Miki et al. · Antimicrobial Agents and Chemotherapy · 2015 · 41 citations · Full text

, , +17

Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors

Tomokazu Yoshinaga, Takahiro Seki, Shigeru Miki et al. · Antiviral Research · 2018 · 24 citations

, , +11

Barrier to Resistance of Dolutegravir in Two-Drug Combinations

Tomokazu Yoshinaga, Shigeru Miki, Shinobu Kawauchi-Miki et al. · Antimicrobial Agents and Chemotherapy · 2019 · 15 citations · Full text

, , +12

1–5 of 5